Through this 100% online Postgraduate diploma, you will acquire competencies in the use of epidemiological surveillance technologies and methods, allowing you to play a crucial role in disease prevention and control" 

Public Health Surveillance plays a fundamental role in protecting and promoting the well-being of society. By monitoring and analyzing data related to the health of the population, this discipline makes it possible to detect and respond early to emerging threats. 

This is how this Postgraduate diploma in Public Health Surveillance was born, in which doctors will explore the essential principles of epidemiological surveillance, including risk assessment, management and communication. In this sense, they will delve into primary prevention research for chronic diseases and interpret epidemiological data related to environmental health, mastering innovative control systems in pharmacovigilance and international disease surveillance. 

They will also analyze both the epidemiology and prevention of communicable and non-communicable diseases. From understanding the risk factors of Cancer, to the usefulness of vaccines in the prevention of Infectious Diseases, a comprehensive view of strategies to address various Public Health conditions will be offered. In addition, the promotion of healthy aging, detection of rare diseases and the identification of major communicable diseases. 

Finally, the ability to design and evaluate intervention studies, as well as to understand their methodological quality will be developed. From the importance of patient safety, to the implementation of strategies based on scientific evidence for the evaluation of Public Health plans, professionals will apply rigorous and updated knowledge in the continuous improvement of Public Health and health care. 

Therefore, an online program of excellent quality has been designed to meet the individual needs of students and eliminate associated problems, such as moving to a physical campus and adapting to fixed schedules. In addition, a revolutionary learning methodology called Relearning, which involves the review of essential concepts to achieve a more solid understanding of the contents. 

This specialized program will provide you with advanced knowledge and practical skills to identify, analyze and respond effectively to Public Health problems. What are you waiting for to enroll?"

This Postgraduate diploma in Public Health Surveillance contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Public Health Surveillance
• The graphic, schematic and eminently practical contents with which it is conceived gather scientific and practical information on those disciplines that are indispensable for professional practice 
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

You will address the quality and methodological correctness of prognostic factor studies, as well as the introduction of patient safety as a key concept in healthcare. Bet on TECH!”

The program’s teaching staff includes professionals from the sector who contribute their work experience to this specializing program, as well as renowned specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations. 

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will gain a profound understanding of research requirements in the primary prevention of Chronic Diseases and the evaluation of effective strategies, as well as the interpretation of epidemiological data related to environmental health"

You will master rare disease detection and neonatal screening programs, as well as evaluate healthy and active aging programs, all through an extensive library of multimedia resources"

The contents of the program will include an understanding of the fundamental principles of epidemiological surveillance, risk assessment and health crisis management, as well as the analysis of self-monitoring and surveillance systems. Therefore, professionals will delve into research in primary prevention of chronic diseases, interpretation of epidemiological data and pharmacovigilance. In addition, they will delve into the epidemiology and prevention of communicable and non-communicable diseases, as well as clinical epidemiology and quality assessment of intervention studies.

You will cover the fundamental principles of health prevention and protection, with a focus on epidemiological surveillance, risk management and risk communication, thanks to the best teaching materials”

Module 1. Public Health Surveillance

1.1. Protection, Prevention and Surveillance in Public Health: Classification, Evaluation, Management and Risk Control and Communication 

1.1.1. Health Protection and Prevention 
1.1.2. Risk Health and Management Surveillance 
1.1.3. Risk Communication Mechanisms and Limitations 

1.2. Self-control and Surveillance Systems: Hazard Analysis and Critical Control Points 

1.2.1. Establishment of Preventive Protocols 
1.2.2. Identification and Risk Assessment 
1.2.3. Implementation and Follow-up Control Points 

1.3. Research and Critical Analysis of Process and Outcome Indicators, Records, and Evaluation Systems Development and Innovation 

1.3.1. Research and Analysis of Indicators 
1.3.2. Recording and Evaluation for Efficient Data Management 
1.3.3. Innovation in Evaluation Systems 

1.4. Research in the Design, Implementation, and Impact Evaluation of Health Protection and Prevention Programs 

1.4.1. Mechanisms for the Design of Health Protection and Prevention Programs 
1.4.2. Implementation of Health Protection and Prevention Programs 
1.4.3. Analysis of the Impact of Health Protection and Prevention Programs 

1.5. Analysis and Interpretation of Epidemiological Data on Environmental Health: Surveillance, Estimation, Plans and Programs 

1.5.1. Importance of Environmental Health in Human Health. 
1.5.2. Exploration of Environmental Epidemiological Data 
1.5.3. Practical Application of Environmental Data Analysis 

1.6. Interpretation of Epidemiological Data on Chronic Diseases and Planning: Surveillance, Estimation, Design of Plans, Programs, and Screening 

1.6.1. Epidemiological Analysis of Chronic Diseases Importance of Monitoring 
1.6.2. Design and Development of Interventions for Chronic Diseases 
1.6.3. Epidemiological Surveillance and Disease Burden Analysis 

1.7. Research in Primary Prevention of Chronic Diseases: Health Protection 

1.7.1. Research in Primary Prevention of Chronic Diseases 
1.7.2. Applied Research in Health Prevention and Protection 
1.7.3. Impact Evaluation and Communication of Results 

1.8. Innovation in Pharmacovigilance Monitoring and Prevention Systems: Alerts and Preventive Interventions 

1.8.1. Importance of Pharmacovigilance Safety in the Use of Drugs 
1.8.2. Advances in Pharmacovigilance Monitoring Systems
1.8.3. Risk Prevention Through Preventive Interventions 

1.9. Models of Response to Alerts, Epidemic Outbreaks and Emergencies Development of Protocols and Procedures 

1.9.1. Response Strategies for Health Emergencies 
1.9.2. Development of Crisis Management Protocols 
1.9.3. Implementation and Evaluation of Emergency Response 

1.10. International Health and Innovation in International Cooperation for Epidemiological Surveillance 

1.10.1. International Health Global Perspective on Epidemiological Surveillance 
1.10.2. Innovation in International Cooperation for Epidemiological Surveillance 
1.10.3. Challenges and Future of International Cooperation in Health

Module 2. Epidemiology and Prevention of Communicable and Non-communicable Diseases

2.1. Cancer Epidemiology: Risk Factors and Primary Prevention 

2.1.1. Descriptive Epidemiology: Incidence, Mortality and Data Sources 
2.1.2. Cancer Risk Factors: Environmental and Occupational 
2.1.3. Other Factors: Ultraviolet Light, Infections, Radiation 

2.2. Risk Factors and Primary Prevention of Cancer: Lifestyle and Screening  

2.2.1. Primary Prevention Risk Factors and Prevention Strategies 
2.2.2. Legislative Measures 
2.2.3. Secondary Prevention 

2.3. Biological Mechanisms of Cardiovascular Disease Estimation of Cardiovascular Risk and Population Prevention 

2.3.1. Ischemic Heart Disease and Stroke 
2.3.2. Epidemiological Indicators 
2.3.3. Classification of Cardiovascular Risk 
2.3.4. Prevention and Control of Cardiovascular Diseases 

2.4. Detection of Rare Diseases and Neonatal Screening 

2.4.1. Rare Diseases 
2.4.2. Newborn Screening Programs 
2.4.3. Neonatal Screening for Congenital Metabolic and Endocrinologic Diseases 

2.5. Comprehensive Approach to Chronic Disease Prevention for Healthy and Sustainable Aging 

2.5.1. Healthy Aging 
2.5.2. Active Aging 
2.5.3. Integrated Prevention 

2.6. Epidemiology of Communicable Diseases: Epidemiologic Surveillance Systems and Notifiable Disease Systems 

2.6.1. Causative Agents 
2.6.2. Time Periods 
2.6.3. Transmission 
2.6.4. Host and Susceptible Population 
2.6.5. Epidemiological Surveillance Systems 

2.7. Utility of Vaccines in the Prevention of Immunopreventable Infectious Diseases 

2.7.1. Analysis of the Importance of Vaccination in the Prevention of Infectious Diseases at the Individual and Community Levels  
2.7.2. Evolution of Vaccines: Types of Vaccines Currently Available 
2.7.3. Mechanisms of Action of Vaccines and Their Impact on the Immune System 
2.7.4. Efficacy and Safety of Vaccines in the Prevention of Infectious Diseases  
2.7.5. Importance of Vaccination in Risk Groups and in the Prevention of Epidemics 
2.7.6. Logistics and Vaccination Programs at the International Level 
2.7.7. Economic and Social Impact of Vaccination in the Prevention of Infectious Diseases 
2.7.8. Research and Analysis of Barriers and Challenges in the Implementation of Vaccination Programs  
2.7.9. Strategies and Measures to Promote Vaccination and to Raise Public Awareness of its Importance 
2.7.10. Evaluation and Critical Analysis of the Scientific Literature Related to Vaccines and their Usefulness in the Prevention of Infectious Diseases 

2.8. Emerging Diseases Epidemic Outbreaks 

2.8.1. Factors Favoring Emerging Diseases 
2.8.2. New Agents and Diseases 
2.8.3. International Health Regulations (IHR) 
2.8.4. Epidemic Outbreaks. Study, Control and Measures: Chemoprophylaxis, Immunoglobulins and Vaccines 

2.9. Viral Hepatitis, HIV infection, AIDS, Sexually Transmitted Infections (STIs) and Tuberculosis 

2.9.1. Hepatitis A: Etiology, Epidemiology and Preventive Measures 
2.9.2. Hepatitis B: Etiology, Epidemiology and Preventive Measures  
2.9.3. Other Viral Hepatitis: Etiology, Epidemiology and Preventive Measures 
2.9.4. HIV: Etiology, Epidemiology and Preventive Measures  
2.9.5. Sexually Transmitted Infections (STIs): Etiology, Epidemiology, and Preventive Measures 
2.9.6. Tuberculosis: Etiology, Epidemiology and Preventive Measures 

2.10. Meningococcal Disease (MD) and Zoonosis: Epidemiology Prevention and Control 

2.10.1.  Epidemiology of Meningococcal Disease 
2.10.2. Prevention and Control of Meningococcal Disease 
2.10.3. Epidemiology of Zoonoses 
2.10.4. Prevention and Control of Zoonoses

Module 3. Clinical Epidemiology

3.1. Design and Quality Assessment of Intervention Studies in Epidemiology 

3.1.1. Intervention Studies, Types and Key Design Elements 
3.1.2. Ethical Aspects of Intervention Research 
3.1.3. Design of Specific Intervention Studies 
3.1.4. Tools for Assessing the Quality of Intervention Studies 
3.1.5. Critical Appraisal of Intervention Studies 
3.1.6. Importance of Design and Quality Assessment 

3.2. Pragmatic vs. Explanatory Randomized Clinical Trials 

3.2.1. Differentiation Between Pragmatic and Explanatory Clinical Trials 
3.2.2. Ethical Implications of Each Approach 
3.2.3. Critical Evaluation of the Methodology and Design of Each Type of Trial 
3.2.4. Application of Knowledge to Clinical Practice and Research 
3.2.5. Promotion of Critical Thinking and Analytical Skills 
3.2.6. Design and Conduct of Clinical Studies 

3.3. Design of Diagnostic Test Studies 

3.3.1. Selection of the Study Population and Definition of Inclusion and Exclusion Criteria 
3.3.2. Determination of the Study Design and Selection of the Reference Methodology 
3.3.3. Calculation of Diagnostic Accuracy and Analysis of Results 

3.4. Evaluation of the Quality of a Diagnostic Test Study 

3.4.1. Study Validity Analysis 
3.4.2. Evaluation of the Accuracy of the Diagnostic Test 
3.4.3. Analysis of the Clinical Utility of the Diagnostic Test 

3.5. Design and Quality Assessment of Prognostic Factor Studies 

3.5.1. Selection and Definition of Prognostic Factors 
3.5.2. Study Design and Selection of the Study Population 
3.5.3. Evaluation of the Quality of the Study and the Prognostic Model 

3.6. Evidence-based Clinical Recommendations: GRADE 1 

3.6.1. Systematic Review of the Scientific Literature Identification of Clinical Recommendations 
3.6.2. Quality of Evidence and Strength of Recommendations 
3.6.3. Clinical Recommendations Applicable to Clinical Practice 
3.6.4. Development of Clinical Protocol or Clinical Guideline Based on the Identified Recommendations  
3.6.5. Implementation and Follow-up of the Clinical Protocol or Guideline in Patient Care  Evidence and Focus on Improving Clinical Outcomes 
3.6.6. Periodic Evaluation, through Monitoring of Clinical Outcome Indicators and Feedback from the Health Professionals Involved 

3.7. Evidence-based Clinical Recommendations: GRADE 2 

3.7.1. Analysis and Synthesis of the Available Evidence in the Scientific Literature for the Development of Recommendations 
3.7.2. Identification and Evaluation of the Quality of the Relevant Studies that Support the Clinical Recommendations 
3.7.3. Application of the Principles of the GRADE Methodology to Establish the Strength and Certainty of Clinical Recommendations  
3.7.4. Developing Clinical practice Guidelines that Incorporate Evidence-based Recommendations and that are Useful for Clinical Decision Making 
3.7.5. Periodic Updating and Revision of Clinical Recommendations Based on the Available Scientific Evidence   

3.8. Evaluation of the Quality of Care 

3.8.1. Quality Criteria and Standards from the Point of View of Safety 
3.8.2. Evaluation of the Effectiveness of the Results obtained through the Actions Evaluated of the Actions Evaluated and their Components 
3.8.3. Measurement of Patient Outcomes and Experiences, Patient-Reported Outcome  Measures (PROM) and Patient-Reported Experience Measures (PREM) 
3.8.4. Indicators for Assessing the Degree of Involvement, Participation and Satisfaction of Healthcare Professionals  

3.9. Incorporation of Patients' Values and Preferences: Shared Decisions 

3.9.1. Effective Communication and Understanding of Values and Preferences 
3.9.2. Education and Counseling on Treatment Options 
3.9.3. Facilitation of Shared Decision Making 

3.10. Patient Safety 

3.10.1. Identification and Recording of Adverse Events 
3.10.2. Analysis of Errors and Underlying Causes 
3.10.3. Implementation of Corrective Actions and Prevention Measures

You will have access to a library of multimedia resources 7 days a week, 24 hours a day"